Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

COVID-19: Will the disease or the cure cause more death?

Craig Goolsby, MD, MEd, Raphaelle H. Rodzik, MPH, Nicole Dacuyan-Faucher, MPH, Keke Schuler, PhD, Thomas Kirsch, MD, MPH
Conditions
April 5, 2020
Share
Tweet
Share

There have been increasing statements in the media to the effect that, for the COVID-19 pandemic, “the cure is worse than the disease,” and that the economic impact of the drastic and widespread quarantines will cause a severe recession that will result in excess deaths. This is very unlikely, as the overall U.S. mortality from unchecked COVID-19 would likely exceed the mortality from an economic recession resulting from the public health measures used to contain its spread.

The currently available medical interventions are limited. There are no known vaccines or proven medication regimens for COVID-19. Travel restrictions initially slowed the spread of the infection to the U.S. But, the limited number of tests prevents widespread case identification, and the very limited public health workforce at the local level makes contact tracing with multiple infections virtually impossible. The remaining strategies which focus on reducing population spread have been employed globally with varying success. These include an array of options ranging from individual case isolation to nationwide “lockdowns.”

The worst-case projections are truly frightening. The U.K.’s Imperial College estimates that 2.2 million Americans will die from COVID-19 and that hospital bed demand will be 30 times greater than supply, if no public health measures are taken. The college’s modeling shows that mortality could be reduced by as much as 90 percent based on the intensity and speed with which five non-pharmaceutical measures are implemented. Even with more hopeful assumptions for infectivity and mortality, the anticipated number of deaths for unchecked COVID-19 is striking. Assuming a best-case scenario similar to a typical influenza outbreak, if 20 percent of the roughly 330 million disease-naive people in the United States became infected, and 0.1 percent died, this would still result in 66,000 deaths from unchecked COVID-19. This would create an overwhelming burden for our hospitals.

Historical context

These numbers contrast with the historical mortality from economic downturns. Studies of the U.S. Great Depression (1929-1933), Great Recession (2007-2009), and other periods of worsening economic conditions, demonstrate that mortality actually decreases during periods of economic downturn. In a 2009 publication, Berzruchka writes that, “economic recessions have paradoxical effects on the mortality trends of populations in rich countries. Contrary to what might have been expected, economic downturns during the 20th century were associated with declines in [all-cause] mortality rates.” Ruhm has shown a procyclical relationship between the economy and mortality – meaning that overall mortality increases during economic expansion and decreases during decline.  Statistically, a one-percent increase in unemployment decreases the predicted death rate by 0.5 percent. A 2009 descriptive analyses of associations in health indicators and economic activity for the period of 1920-1940 found that population health evolves better during recessions than expansions.

Mortality from suicide is a notable exception, as it is countercyclical, and increases during economic downturn. However, this increased mortality from suicide does not outweigh the net decrease in overall societal mortality. These mortality findings only apply to higher-income countries. Countries with an annual GDP of less than approximately $5,000 to $10,000 per capita (in 2009 dollars) would expect to see mortality improvements with economic growth.

Several factors may explain these counterintuitive trends. There are fewer traffic and industrial accidents when there is less economic activity, as people are not commuting or performing work. People also have less work-related stress, during times of economic downturn, which might exacerbate health conditions. In addition, without disposable income, people are less likely to engage in behaviors associated with poor health conditions, including drinking and smoking. Consequently, decreases in obesity and cardiovascular disease are often seen during an economic recession. Moreover, people are often home spending time with families and friends and are more physically active during an economic downturn compared to a period of economic expansion.

The disease is more deadly

Public health decisions in the face of the uncertain impact of a new threat are complicated, but when lives are at stake, public health leaders usually recommend the most conservative course to prevent deaths. Our current limited understanding of the transmission, infectivity, presentation, and fatality of COVID-19 has made choosing the best interventions to reduce mortality even more difficult. But watching the horrors of the impact of the thousands of patients overwhelming the hospitals and healthcare workers in Italy, Spain, and New York, is ample evidence that this pandemic requires drastic interventions.

It is clear from historical precedent that the “cure” of public health strategies to suppress COVID-19 will result in significantly less mortality than any potential mortality caused by a resultant economic downturn.

Craig Goolsby and Thomas Kirsch are emergency physicians. Raphaelle H. Rodzik and Nicole Dacuyan-Faucher are epidemiologists. Keke Schuler is a psychologist.

Image credit: Shutterstock.com

Prev

The gift COVID gave me

April 5, 2020 Kevin 0
…
Next

Undergoing an appendectomy in a pandemic

April 5, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease, Public Health & Policy

Post navigation

< Previous Post
The gift COVID gave me
Next Post >
Undergoing an appendectomy in a pandemic

ADVERTISEMENT

Related Posts

  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • State sanctioned executions in the age of COVID-19

    Kasey Johnson, DO
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh
  • Starting medical school in the midst of COVID-19

    Horacio Romero Castillo
  • COVID-19 shows why we need health insurance

    Jingyi Liu, MD

More in Conditions

  • Medicaid lags behind on Alzheimer’s blood test coverage

    Amanda Matter
  • Why transgender health care needs urgent reform and inclusive practices

    Angela Rodriguez, MD
  • Why the Sean Combs trial is a wake-up call for HIV prevention

    Catherine Diamond, MD
  • New surge in misleading ads about diabetes on social media poses a serious health risk

    Laura Syron
  • mRNA post vaccination syndrome: Is it real?

    Harry Oken, MD
  • The critical role of nurse practitioners in colorectal cancer screening

    Elisabeth Evans, FNP
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Gen Z’s DIY approach to health care

      Amanda Heidemann, MD | Education
    • What street medicine taught me about healing

      Alina Kang | Education
    • Smart asset protection strategies every doctor needs

      Paul Morton, CFP | Finance
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • How IMGs can find purpose in clinical research [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

COVID-19: Will the disease or the cure cause more death?
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...